Sale!

ATP2A2 Gene Acrokeratosis Verruciformis Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ATP2A2 gene acrokeratosis verruciformis genetic test is a specialized diagnostic procedure aimed at identifying mutations in the ATP2A2 gene, which are associated with the rare skin disorder known as acrokeratosis verruciformis. This condition is characterized by the development of flat warts, primarily on the hands and feet, and is known to follow an autosomal dominant pattern of inheritance. The test involves analyzing the patient’s DNA to detect any genetic abnormalities that may indicate the presence of or predisposition to acrokeratosis verruciformis.

Conducted at DNA Labs UAE, a leading facility in genetic testing, this test is priced at 4400 AED. DNA Labs UAE employs cutting-edge technology and follows stringent protocols to ensure accurate and reliable results. The test is essential for individuals with a family history of the condition or those exhibiting symptoms, as it can provide crucial information for diagnosis, management, and understanding the risk of passing the condition to offspring.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ATP2A2 Gene Acrokeratosis verruciformis Genetic Test

Test Name: ATP2A2 Gene Acrokeratosis verruciformis Genetic Test

Components: NGS Technology

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Osteology Dermatology Immunology Disorders

Doctor: Dermatologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for ATP2A2 Gene Acrokeratosis verruciformis NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ATP2A2 Gene Acrokeratosis verruciformis NGS Genetic DNA Test gene ATP2A2

Test Details

The ATP2A2 gene is associated with a condition called acrokeratosis verruciformis (AKV). AKV is a rare genetic disorder characterized by the development of wart-like skin lesions on the hands and feet. These lesions can be persistent and resistant to treatment.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of AKV, NGS genetic testing can be used to identify mutations or variations in the ATP2A2 gene that may be responsible for causing the condition. By analyzing the ATP2A2 gene, NGS genetic testing can help confirm a diagnosis of AKV and provide valuable information about the specific genetic changes involved. This information can be useful for understanding the underlying cause of the condition, predicting disease progression, and guiding treatment decisions.

It is important to note that genetic testing for AKV is typically performed by healthcare professionals with expertise in genetics. If you suspect you or someone you know may have AKV, it is recommended to consult with a healthcare provider who can assess your specific situation and guide you through the appropriate testing process.

Test Name ATP2A2 Gene Acrokeratosis verruciformis Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Osteology Dermatology Immunology Disorders
Doctor Dermatologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ATP2A2 Gene Acrokeratosis verruciformis NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ATP2A2 Gene Acrokeratosis verruciformis NGS Genetic DNA Test gene ATP2A2
Test Details

The ATP2A2 gene is associated with a condition called acrokeratosis verruciformis (AKV). AKV is a rare genetic disorder characterized by the development of wart-like skin lesions on the hands and feet. These lesions can be persistent and resistant to treatment.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of AKV, NGS genetic testing can be used to identify mutations or variations in the ATP2A2 gene that may be responsible for causing the condition.

By analyzing the ATP2A2 gene, NGS genetic testing can help confirm a diagnosis of AKV and provide valuable information about the specific genetic changes involved. This information can be useful for understanding the underlying cause of the condition, predicting disease progression, and guiding treatment decisions.

It is important to note that genetic testing for AKV is typically performed by healthcare professionals with expertise in genetics. If you suspect you or someone you know may have AKV, it is recommended to consult with a healthcare provider who can assess your specific situation and guide you through the appropriate testing process.